Skip to main content
OpenTrials

Clinical trial discovery

Find Clinical Trials

Search studies by condition, treatment, location, eligibility, or trial identifier.

Showing 1–20 of 56 trials

Active filters

Clinical trials found

Published and searchable clinical trials

Searching for clinical trials...
Recruiting

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

NCT07649525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Frailty, +19 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Eastbourne District General Hospital Eastbourne, United Kingdom
  • St James University Hospital Leeds, United Kingdom
  • The Clatterbridge Cancer Centre - Liverpool Liverpool, United Kingdom
View Trial Details
Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

NCT07280013

Conditions
Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Health, Jonsson Comprehensive Cancer Center Santa Monica, California, United States
  • University of Florida Gainesville, Florida, United States
View all 20 locations
View Trial Details
Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

NCT06974786

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

NCT07477587

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • D&H National Research Center Margate, Florida, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 81 locations
View Trial Details
Recruiting

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

NCT07214324

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • Istituto Ortopedico Rizzoli IRCCS Bologna, Italy
  • UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco" Catania, Italy
  • UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone" Palermo, Italy
  • S.C Ematologia - Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy
View Trial Details
Recruiting

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

NCT07107529

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • IT-Ascoli Piceno-Ospedale Mazzoni [01-016] Ascoli Piceno, Italy
  • IT-Bari-A.O.U. Consorziale Policlinico - Medicina Interna [01-018] Bari, Italy
  • IT-Bergamo-A.O. Papa Giovanni XXIII [01-003] Bergamo, Italy
  • IT-Bologna-A.O.U. di Bologna - Policlinico S. Orsola Malpighi [01-004] Bologna, Italy
View all 29 locations
View Trial Details
Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05908409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
  • Hospital Universitari Vall d'hebron Barcelona, Spain
  • Hospital Durán i Reynals - ICO L´Hospitalet Barcelona, Spain
View Trial Details
Recruiting

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

NCT06821880

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia (CLL), +20 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Tyrolia, Austria
  • Medizinische Universität Graz Graz, Austria
  • BKH Kufstein Kufstein, Austria
  • Onkologischer Schwerpunkt am Oskar-Helene-Heim Berlin, Germany
View Trial Details
Recruiting

A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence

NCT06767254

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS Meldola, Forlì-Cesena, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • ARNAS "G. Brotzu" di Cagliari Cagliari, Italy
  • Azienda Ospedaliera Universitaria Federico II Naples, Italy
View Trial Details